Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2016 08:45 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics Announces Registered Direct Offering

NEWTOWN, PA., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
December 14, 2015 09:15 ET | Source: Traws Pharma, Inc.

Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Wednesday, December 16, in New York City

NEWTOWN, Pa., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
December 07, 2015 19:01 ET | Source: Traws Pharma, Inc.

Onconova Presents Positive Data From Phase 2 Combination Trial of Oral Rigosertib and Azacitidine in Higher-Risk Myelodysplastic Syndromes at 2015 ASH Annual Meeting

--Combination Achieved 77% Overall Response Rate in all MDS Patients-- --Overall Response Rate of 84% in treatment-naïve MDS Patients-- --Response Rate of 64% in MDS Patients who had Previously...
December 07, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Enrolls First Patient in Phase 3 INSPIRE Trial of Rigosertib

NEWTOWN, Pa., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
November 25, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. to Participate in Panel Discussions at Two Investor Conferences in December

NEWTOWN, Pa., Nov. 25, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
November 11, 2015 16:05 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. Reports Recent Business Highlights and Third Quarter 2015 Financial Results

NEWTOWN, Pa., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
November 05, 2015 09:04 ET | Source: Traws Pharma, Inc.

Onconova Announces Data Presentation From Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at the 2015 ASH Annual Meeting

NEWTOWN, Pa., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
October 29, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. to Present New Data on Briciclib and Next-Generation CDK4/6 Inhibitor, ON 123300, at 2015 AACR-NCI-EORTC Meeting

NEWTOWN, Pa., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
October 08, 2015 16:55 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics Announces $16.5M Share Purchase Agreement With Lincoln Park Capital Fund

NEWTOWN, Pa., Oct. 08, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
September 02, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. to Present Corporate Update at Rodman & Renshaw 17th Annual Global Investment Conference

NEWTOWN, Pa., Sept. 02, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...